Gene editing can treat people who are at risk of hearing loss caused due to genetic mutations, otherwise known as autosomal dominant hearing diseases, reveals a new study.
Xue (Sherry) Gao, who joined Rice in the fall as the Ted N. Law Assistant Professor of Chemical and Biomolecular Engineering, is co-lead author of a new Nature paper.
Hearing Loss Symptom Evaluation
Hearing loss is a common problem that could occur in childhood or often develops with age or is caused by repeated exposure to loud noises. Keep abreast on its causes and symptoms.
Advertisement
‘A ribonucleotide (RNP) protein complex injected into the cochleae can help treat genetic hearing diseases.’
Tweet it Now
Gao performed the research while a postdoctoral associate under the guidance of David Liu at Harvard University. She said that while hearing diseases are typically not life-threatening, hearing loss is the most common human sensory impairment and has a substantial impact on individuals and society.
Many genetic mutations affect the sensory hair cells that amplify acoustic vibrations and translate them into electrical nerve signals.
Gao said humans are born with about 12,000 hair cells that do not regenerate spontaneously if damaged. It has been reported that one in every 1,000 infants born in the United States has genetic mutations that contribute to deafness. Nevertheless, she said, few treatments are available to slow or reverse genetic deafness.
![Hearing Loss in Young Children and Early Intervention]( "Hearing Loss in Young Children and Early Intervention")
Early identification of hearing loss in infants and young children and treating hearing impairment can go a long way to integrate them into the society of talking people.
The researchers used rodent models of human genetic disease since a rodent cochlea, the organ in the inner ear that sends sounds to the brain is strikingly similar to that of humans, Gao said. They focused on editing hair cells inside the cochlea, which they found suitable for the delivery of one-time, nonreplicable edits through Cas9/single-guide RNA.
The RNA is a ribonucleotide (RNP) protein complex designed to specifically disrupt genes associated with hearing loss.
"Delivering the RNP complex instead of DNA into the cochleae showed significantly fewer off-target effects," Gao said. This enabled the researchers to effectively disrupt one genomic site containing a single point mutation and avoid the billions of other sites available for modification.
Eight weeks after injecting the protein complex into the cochleae of rodents with progressive, genetic hearing loss, the researchers observed higher hair cell survival rates compared with those in a control group that did not receive the injection.
Tests that measured brain waves in response to audio cues showed the treatment significantly preserves the animals' hearing compared with the control group. The treatment also helped preserve the injected animals' acoustic behavioral reflexes, according to the researchers.
"We believe this is a leading study on using Crispr-Cas9 genome editing technology to treat genetic hearing diseases," said Gao, whose lab is at Rice's BioScience Research Collaborative. "We hope to develop more advanced genome-editing tools and test them on other animal species to demonstrate their safety and effectiveness as we move them toward humans.
"I'm definitely looking for collaborators at Rice, the Texas Medical Center and in Houston who also are interested in developing genome-editing technology," she said.
Gao's primary collaborators on the Nature paper were co-lead author Yong Tao and Zheng-Yi Chen of the Massachusetts Eye and Ear Infirmary.
The Defense Advanced Research Projects Agency and the National Institutes of Health supported the research.
Source: Eurekalert
Gao said humans are born with about 12,000 hair cells that do not regenerate spontaneously if damaged. It has been reported that one in every 1,000 infants born in the United States has genetic mutations that contribute to deafness. Nevertheless, she said, few treatments are available to slow or reverse genetic deafness.
Hearing Loss in Young Children and Early Intervention
Early identification of hearing loss in infants and young children and treating hearing impairment can go a long way to integrate them into the society of talking people.
Advertisement
The researchers used rodent models of human genetic disease since a rodent cochlea, the organ in the inner ear that sends sounds to the brain is strikingly similar to that of humans, Gao said. They focused on editing hair cells inside the cochlea, which they found suitable for the delivery of one-time, nonreplicable edits through Cas9/single-guide RNA.
The RNA is a ribonucleotide (RNP) protein complex designed to specifically disrupt genes associated with hearing loss.
"Delivering the RNP complex instead of DNA into the cochleae showed significantly fewer off-target effects," Gao said. This enabled the researchers to effectively disrupt one genomic site containing a single point mutation and avoid the billions of other sites available for modification.
Eight weeks after injecting the protein complex into the cochleae of rodents with progressive, genetic hearing loss, the researchers observed higher hair cell survival rates compared with those in a control group that did not receive the injection.
Tests that measured brain waves in response to audio cues showed the treatment significantly preserves the animals' hearing compared with the control group. The treatment also helped preserve the injected animals' acoustic behavioral reflexes, according to the researchers.
"We believe this is a leading study on using Crispr-Cas9 genome editing technology to treat genetic hearing diseases," said Gao, whose lab is at Rice's BioScience Research Collaborative. "We hope to develop more advanced genome-editing tools and test them on other animal species to demonstrate their safety and effectiveness as we move them toward humans.
"I'm definitely looking for collaborators at Rice, the Texas Medical Center and in Houston who also are interested in developing genome-editing technology," she said.
Gao's primary collaborators on the Nature paper were co-lead author Yong Tao and Zheng-Yi Chen of the Massachusetts Eye and Ear Infirmary.
The Defense Advanced Research Projects Agency and the National Institutes of Health supported the research.
Source: Eurekalert
Noise-Induced Hearing Loss
Noise-induced hearing loss is the hearing impairment that occurs due to noise exposure. Noise-related hearing loss is also listed among occupational illnesses.
Advertisement
 Occupational Hearing LossNoise-Induced hearing loss is one of the major avoidable causes of hearing loss and is also one of the major occupational hazards. | Advertisement
|
Advertisement
Recommended Readings
Latest Genetics & Stem Cells News
Among MS patients, the stem cells showed a neuroprotective role, guarding nerve cells from further decline.
New possibilities for research on digestive diseases have been set by complete decoding of the Y chromosome.
UK has given the green light to the world's inaugural gene therapy for sickle-cell disease and thalassemia.
1 in 25 people had a genotype linked to short lifetime, which includes BRCA2 and LDLR genes, that reduced lifespan by seven years, and six years respectively.
The study findings help redefine osteoarthritis as a reversible loss of key cartilage stem cells, not just 'wear and tear'."